[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

EA201990513A1 - АГОНИСТ PPARγ ДЛЯ ЛЕЧЕНИЯ ПОРАЖЕНИЙ КОСТЕЙ - Google Patents

АГОНИСТ PPARγ ДЛЯ ЛЕЧЕНИЯ ПОРАЖЕНИЙ КОСТЕЙ

Info

Publication number
EA201990513A1
EA201990513A1 EA201990513A EA201990513A EA201990513A1 EA 201990513 A1 EA201990513 A1 EA 201990513A1 EA 201990513 A EA201990513 A EA 201990513A EA 201990513 A EA201990513 A EA 201990513A EA 201990513 A1 EA201990513 A1 EA 201990513A1
Authority
EA
Eurasian Patent Office
Prior art keywords
treatment
bone diseases
pparγ agonist
pparγ
agonist
Prior art date
Application number
EA201990513A
Other languages
English (en)
Inventor
Деннис Ланфир
Original Assignee
Интекрин Терапьютикс, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Интекрин Терапьютикс, Инк. filed Critical Интекрин Терапьютикс, Инк.
Publication of EA201990513A1 publication Critical patent/EA201990513A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Management, Administration, Business Operations System, And Electronic Commerce (AREA)

Abstract

Способы лечения поражения костей, включая остеопороз или его симптомы, с использованием агонистов PPARγ и, в частности, соединения формулы (I), известного как INT131
EA201990513A 2016-08-18 2017-08-18 АГОНИСТ PPARγ ДЛЯ ЛЕЧЕНИЯ ПОРАЖЕНИЙ КОСТЕЙ EA201990513A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662376732P 2016-08-18 2016-08-18
PCT/US2017/047584 WO2018035449A1 (en) 2016-08-18 2017-08-18 Pparϒ agonist for treatment of bone disorders

Publications (1)

Publication Number Publication Date
EA201990513A1 true EA201990513A1 (ru) 2019-08-30

Family

ID=61197122

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201990513A EA201990513A1 (ru) 2016-08-18 2017-08-18 АГОНИСТ PPARγ ДЛЯ ЛЕЧЕНИЯ ПОРАЖЕНИЙ КОСТЕЙ

Country Status (11)

Country Link
US (1) US20190167660A1 (ru)
EP (1) EP3500269A4 (ru)
JP (2) JP2019524889A (ru)
KR (1) KR20190065252A (ru)
CN (1) CN109843292A (ru)
AU (1) AU2017313842A1 (ru)
BR (1) BR112019003133A2 (ru)
CA (1) CA3033971A1 (ru)
EA (1) EA201990513A1 (ru)
SG (2) SG11201901328VA (ru)
WO (1) WO2018035449A1 (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20220070057A (ko) 2015-03-09 2022-05-27 인테크린 테라퓨틱스, 아이엔씨. 비알코올성 지방간 질환 및/또는 지방이영양증의 치료 방법
EP3606527A1 (en) 2017-04-03 2020-02-12 Coherus Biosciences, Inc. Ppar-gamma agonist for treatment of progressive supranuclear palsy

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0301146A3 (en) * 2000-04-28 2004-08-30 Sankyo Co 2-chlor-5-nitrophenyl carboxamide derivatives, pharmaceutical compositions containing them and their use
US7223761B2 (en) * 2003-10-03 2007-05-29 Amgen Inc. Salts and polymorphs of a potent antidiabetic compound
EP1722789A2 (en) * 2004-03-08 2006-11-22 Amgen Inc. Therapeutic modulation of ppar (gamma) activity
EA201792096A3 (ru) * 2013-01-30 2018-05-31 Интекрин Терапьютикс, Инк. РАППγ АГОНИСТЫ ДЛЯ ЛЕЧЕНИЯ РАССЕЯННОГО СКЛЕРОЗА
EP3203999B1 (en) * 2014-10-10 2020-01-08 Liminal Biosciences Limited Substituted aromatic compounds and pharmaceutical compositions for the prevention and treatment of osteoporosis

Also Published As

Publication number Publication date
AU2017313842A1 (en) 2019-03-07
US20190167660A1 (en) 2019-06-06
BR112019003133A2 (pt) 2019-05-21
JP2022116294A (ja) 2022-08-09
KR20190065252A (ko) 2019-06-11
JP2019524889A (ja) 2019-09-05
CN109843292A (zh) 2019-06-04
EP3500269A1 (en) 2019-06-26
CA3033971A1 (en) 2018-02-22
SG10202101500WA (en) 2021-03-30
SG11201901328VA (en) 2019-03-28
WO2018035449A1 (en) 2018-02-22
EP3500269A4 (en) 2020-04-15

Similar Documents

Publication Publication Date Title
PH12019550050A1 (en) Isoxazole analogs as fxr agonists and methods of use thereof
CU20210029A7 (es) Inhibidores de proteína tirosina fosfatasa shp2 útiles en el tratamiento de enfermedades
EA201890308A1 (ru) Замещенные азасоединения как ингибиторы irak-4
EA201800367A1 (ru) Способы лечения болезни хантингтона
EA201791018A1 (ru) Производные 6-амино-7-бицикло-7-деазапурина в качестве ингибиторов протеинкиназы
EA201790078A1 (ru) Ингибиторы mnk и связанные с ними способы
EA201890307A1 (ru) Индазольные и азаиндазольные соединения как ингибиторы irak-4
EA201691135A1 (ru) Новые ингибиторы глутаминазы
EA201692079A1 (ru) Ингибиторы лизин-специфической деметилазы-1
MX2020001757A (es) Compuestos, sales de los mismos y metodos para el tratamiento de enfermedades.
EA201691516A1 (ru) Дигидропирролопиридиновые ингибиторы ror-гамма
MY195437A (en) Methods of Treatment for Cholestatic and Fibrotic Diseases
CR20200362A (es) CICLOPROPILAMINA COMO INHIBIDORES DE LA LSD1 (Divisional 2016-0395)
EA201591382A1 (ru) Ингибиторы гистондеметилаз
EA201792205A1 (ru) Гетероциклические соединения как ингибиторы lsd1
EA201400735A1 (ru) Производные альфа-амино бороновой кислоты, селективные ингибиторы иммунопротеасомы
EA201790273A1 (ru) Флагеллиновые композиции и их применение
EA201791095A1 (ru) Способ лечения рака
EA201692480A1 (ru) Фармацевтическая композиция
BR112016015236A2 (pt) inibidores de serina/treonina quinase
EA201890567A1 (ru) Способ лечения рака
EA201791451A1 (ru) 5-[(пиперазин-1-ил)-3-оксо-пропил]-имидазолидин-2,4-дионовые производные в качестве ингибиторов adamts для лечения остеоартрита
EA202091676A1 (ru) Способ лечения потери костной массы альвеолярного отростка посредством применения антител к склеростину
BR112017006420A2 (pt) derivados de ácido borônico
BR112015006037A2 (pt) métodos para tratamento de hcv